References
AHMAD, P.M., STIRLING, L.A., AHMAD, F., 1981. Partial Characterization of Fatty Acid Synthase of Propionibacterium shermanii. Microbiology 127, 121–129. https://doi.org/10.1099/00221287-127-1-121
Arung, E.T., Wicaksono, B.D., Handoko, Y.A., Kusuma, I.W., Yulia, D., Sandra, F., 2009. Anti-Cancer Properties of Diethylether Extract of Wood from Sukun (Artocarpus altilis) in Human Breast Cancer (T47D) Cells. Tropical Journal of Pharmaceutical Research 8. https://doi.org/10.4314/tjpr.v8i4.45223
Bhatt, A., Molle, V., Besra, G.S., Jacobs, W.R., Kremer, L., 2007. The Mycobacterium tuberculosis FAS-II condensing enzymes: their role in mycolic acid biosynthesis, acid-fastness, pathogenesis and in future drug development. Mol. Microbiol. 64, 1442–1454. https://doi.org/10.1111/j.1365-2958.2007.05761.x
Brusselmans, K., De Schrijver, E., Heyns, W., Verhoeven, G., Swinnen, J.V., 2003. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int. J. Cancer 106, 856–862. https://doi.org/10.1002/ijc.11317
Chalbos, D., Chambon, M., Ailhaud, G., Rochefort, H., 1987. Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J. Biol. Chem. 262, 9923–9926.
Deepa, P.R., Vandhana, S., Krishnakumar, S., 2013. Fatty acid synthase inhibition induces differential expression of genes involved in apoptosis and cell proliferation in ocular cancer cells. Nutr Cancer 65, 311–316. https://doi.org/10.1080/01635581.2013.748923
Dixit, R.B., Suseela, M.R., 2013. Cyanobacteria: potential candidates for drug discovery. Antonie Van Leeuwenhoek 103, 947–961. https://doi.org/10.1007/s10482-013-9898-0
Dutler, H., Kull, A., Mislin, R., 1971. Fatty acid synthetase from pig liver. 2. Characterization of the enzyme complex with oxidoreductase activity for alicyclic ketones as a fatty acid synthetase. Eur. J. Biochem. 22, 213–217.
Filimonov, D.A., Akimov, D.V., Poroikov, V.V., 2004. The Method of Self-Consistent Regression for the Quantitative Analysis of Relationships Between Structure and Properties of Chemicals. Pharmaceutical Chemistry Journal 38, 21–24. https://doi.org/10.1023/B:PHAC.0000027639.17115.5d
Friesner, R.A., Murphy, R.B., Repasky, M.P., Frye, L.L., Greenwood, J.R., Halgren, T.A., Sanschagrin, P.C., Mainz, D.T., 2006. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 49, 6177–6196. https://doi.org/10.1021/jm051256o
Gago, G., Diacovich, L., Arabolaza, A., Tsai, S.-C., Gramajo, H., 2011. Fatty acid biosynthesis in actinomycetes. FEMS Microbiol. Rev. 35, 475–497. https://doi.org/10.1111/j.1574-6976.2010.00259.x
Kridel, S.J., Axelrod, F., Rozenkrantz, N., Smith, J.W., 2004. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 64, 2070–2075.
Kuhajda, F.P., Jenner, K., Wood, F.D., Hennigar, R.A., Jacobs, L.B., Dick, J.D., Pasternack, G.R., 1994. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 6379–6383.
Kuhajda, F.P., Pizer, E.S., Li, J.N., Mani, N.S., Frehywot, G.L., Townsend, C.A., 2000. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl. Acad. Sci. U.S.A. 97, 3450–3454. https://doi.org/10.1073/pnas.050582897
Li, X.-C., Joshi, A.S., ElSohly, H.N., Khan, S.I., Jacob, M.R., Zhang, Z., Khan, I.A., Ferreira, D., Walker, L.A., Broedel, S.E., Raulli, R.E., Cihlar, R.L., 2002. Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies. J. Nat. Prod. 65, 1909–1914. https://doi.org/10.1021/np020289t
Lipinski, C.A., Lombardo, F., Dominy, B.W., Feeney, P.J., 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26.
Liu, B., Wang, Y., Fillgrove, K.L., Anderson, V.E., 2002. Triclosan inhibits enoyl-reductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother. Pharmacol. 49, 187–193. https://doi.org/10.1007/s00280-001-0399-x
Liu, H., Liu, J.-Y., Wu, X., Zhang, J.-T., 2010. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int J Biochem Mol Biol 1, 69–89.
Loftus, T.M., Jaworsky, D.E., Frehywot, G.L., Townsend, C.A., Ronnett, G.V., Lane, M.D., Kuhajda, F.P., 2000. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379–2381.
Lupu, R., Menendez, J.A., 2006. Pharmacological inhibitors of Fatty Acid Synthase (FASN)–catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol 7, 483–493.
Maier, T., Leibundgut, M., Boehringer, D., Ban, N., 2010. Structure and function of eukaryotic fatty acid synthases. Q. Rev. Biophys. 43, 373–422. https://doi.org/10.1017/S0033583510000156
Migita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra, G., Inazuka, F., Grisanzio, C., Palescandolo, E., Shin, E., Fiore, C., Xie, W., Kung, A.L., Febbo, P.G., Subramanian, A., Mucci, L., Ma, J., Signoretti, S., Stampfer, M., Hahn, W.C., Finn, S., Loda, M., 2009. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J. Natl. Cancer Inst. 101, 519–532. https://doi.org/10.1093/jnci/djp030
Moche, M., Schneider, G., Edwards, P., Dehesh, K., Lindqvist, Y., 1999. Structure of the complex between the antibiotic cerulenin and its target, beta-ketoacyl-acyl carrier protein synthase. J. Biol. Chem. 274, 6031–6034.
Ohno, T., Awaya, J., Kesado, T., Nomura, S., Ōmura, S., 1974. Mechanism of Action of CM-55, a Synthetic Analogue of the Antilipogenic Antibiotic Cerulenin. Antimicrob Agents Chemother 6, 387–392.
Pappenberger, G., Benz, J., Gsell, B., Hennig, M., Ruf, A., Stihle, M., Thoma, R., Rudolph, M.G., 2010. Structure of the human fatty acid synthase KS-MAT didomain as a framework for inhibitor design. J. Mol. Biol. 397, 508–519. https://doi.org/10.1016/j.jmb.2010.01.066
Rendina, A.R., Cheng, D., 2005. Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates. Biochem. J. 388, 895–903. https://doi.org/10.1042/BJ20041963
Trajtenberg, F., Altabe, S., Larrieux, N., Ficarra, F., de Mendoza, D., Buschiazzo, A., Schujman, G.E., 2014. Structural insights into bacterial resistance to cerulenin. FEBS J. 281, 2324–2338. https://doi.org/10.1111/febs.12785
Vazquez-Martin, A., Colomer, R., Brunet, J., Lupu, R., Menendez, J.A., 2008. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif. 41, 59–85. https://doi.org/10.1111/j.1365-2184.2007.00498.x
von Wettstein-Knowles, P., Olsen, J.G., McGuire, K.A., Henriksen, A., 2006. Fatty acid synthesis. Role of active site histidines and lysine in Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases. FEBS J. 273, 695–710. https://doi.org/10.1111/j.1742-4658.2005.05101.x
Wakil, S.J., 1989. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28, 4523–4530. https://doi.org/10.1021/bi00437a001
Wang, Y.Y., Kuhajda, F.P., Li, J., Finch, T.T., Cheng, P., Koh, C., Li, T., Sokoll, L.J., Chan, D.W., 2004. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer. J. Exp. Ther. Oncol. 4, 101–110.
White, S.W., Zheng, J., Zhang, Y.-M., Rock, null, 2005. The structural biology of type II fatty acid biosynthesis. Annu. Rev. Biochem. 74, 791–831. https://doi.org/10.1146/annurev.biochem.74.082803.133524
Wijffels, R.H., Kruse, O., Hellingwerf, K.J., 2013. Potential of industrial biotechnology with cyanobacteria and eukaryotic microalgae. Curr. Opin. Biotechnol. 24, 405–413. https://doi.org/10.1016/j.copbio.2013.04.004
Zhou, W., Simpson, P.J., McFadden, J.M., Townsend, C.A., Medghalchi, S.M., Vadlamudi, A., Pinn, M.L., Ronnett, G.V., Kuhajda, F.P., 2003. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. Cancer Res. 63, 7330–7337.